Dr. Dowdy is a cancer biologist, specializing in RNAi therapeutics and G1 cell cycle control. He received his PhD in Molecular Genetics from UC Irvine with Eric Stanbridge (1990) working on tumor suppressor genes and performed his postdoctoral fellowship with Bob Weinberg at MIT working on the biochemistry of the Rb tumor suppressor gene (1990-1994). From 1994-2001, He was an Assistant Professor at Washington University School of Medicine. In 2001, He moved his lab to UCSD School of Medicine, where he is a Professor in the Dept. of Cellular & Molecular Medicine. He was also a Howard Hughes Medical Institute Investigator from 1994-2012. Dr. Dowdy’s lab developed the synthesis of RNAi triggers containing neutral, bioreversible phosphotriester groups to increase stability and deliverability. He actively serves on Science Advisory Boards for biotechs, pharmas and non-profit institutes.